Propranolol, a potential lupus-inducing drug, induced stronger AhR activation in the PBMCs of SLE patients than in the control group, and signs of AhR activation were also shown in skin tissues related to lesion expression. The gene discussed is AHR; the disease is systemic lupus erythematosus.